RebeccaVasquezMD

Dermatology • Dallas, TX

Cosmetic Dermatology

Assistant Professor at UT Southwestern Medical Center

Join to view full profile

Dr. Vasquez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Vasquez's full profile

Already have an account?

Office
5323 Harry Hines Boulevard
Dallas, TX 75390
Phone+1 214-645-2400

Fax+1 214-645-2405

Education & Training

University of Texas Southwestern Medical CenterResidency, Dermatology, 2012 - 2015
Tulane UniversityResidency, Internal Medicine, 2010 - 2011
University of Texas Southwestern Medical SchoolClass of 2010

Certifications & Licensure

TX State Medical License 2015 - 2025
NY State Medical License 2008 - 2016
CA State Medical License 2010 - 2011
American Board of Dermatology Dermatology

Publications & Presentations

PubMed

47 citations
A multicentre, cross-sectional study on quality of life in patients with cutaneous lupus erythematosus
Rebecca Vasquez, D. Wang, Q. P. Tran, Beverley Adams-Huet, Mary-Margaret Chren
The British Journal of Dermatology. 2013-01-01
44 citations
A randomized, double-blinded, placebo-controlled trial of oral Polypodium leucotomos extract as an adjunct to sunscreen in the treatment of melasma.
Ammar Ahmed, Isha E. Lopez, Francisco Perese, Rebecca Vasquez, Linda S. Hynan
JAMA Dermatology. 2013-08-01
18 citations
Clinical features of patients with morphea and the pansclerotic subtype: a cross-sectional study from the morphea in adults and children cohort.
Andrew Kim, Nicholas Marinkovich, Rebecca Vasquez, Heidi Jacobe
The Journal of Rheumatology. 2014-01-01

Press Mentions

Black Men Have Higher Risk of Dying from MelanomaAugust 31st, 2023
Understanding the Association Between Social Determinants of Health and Receipt of Immunotherapy for MelanomaMay 14th, 2024